477 results on '"Machet, Laurent"'
Search Results
2. An open label, non-randomised, phase IIIb study of trametinib in combination with dabrafenib in patients with unresectable (stage III) or distant metastatic (stage IV) BRAF V600-mutant melanoma: A subgroup analysis of patients with brain metastases
3. Microbubble-Assisted Ultrasound for Imaging and Therapy of Melanoma Skin Cancer: A Systematic Review
4. Evaluation of the benefit of thermal spa therapy in plaque psoriasis: the PSOTHERMES randomized clinical trial
5. Efficacy, safety and factors associated with disease progression in patients with unresectable (stage III) or distant metastatic (stage IV) BRAF V600-mutant melanoma: An open label, non-randomized, phase IIIb study of trametinib in combination with dabrafenib
6. Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): health-related quality-of-life results from a double-blind, randomised, controlled, phase 3 trial
7. Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): distant metastasis-free survival results from a double-blind, randomised, controlled, phase 3 trial
8. Topical versus oral corticosteroids in moderate drug reaction with eosinophilia and systemic symptoms: A multicenter randomized clinical trial.
9. Efficacy of Spironolactone Compared with Doxycycline in Moderate Acne in Adult Females: Results of the Multicentre, Controlled, Randomized, Double-blind Prospective and Parallel Female Acne Spironolactone vs doxyCycline Efficacy (FASCE) Study
10. Transdermal Transport by Sonophoresis
11. High pre-treatment neutrophil-to-lymphocyte ratio in patients with dermatomyositis/polymyositis predicts an increased risk of cancer
12. Response to BRAF and MEK Inhibitors in BRAF Thr599dup–Mutated Melanoma
13. Large International Validation of ABSIS and PDAI Pemphigus Severity Scores
14. Double-hit or dual expression of MYC and BCL2 in primary cutaneous large B-cell lymphomas
15. MAGE-A3 immunotherapeutic as adjuvant therapy for patients with resected, MAGE-A3-positive, stage III melanoma (DERMA): a double-blind, randomised, placebo-controlled, phase 3 trial
16. Reconnaissance et prise en charge initiale du mélanome par des médecins généralistes : enquête dans un département rural à très faible densité médicale
17. STAT3 Mediates Nilotinib Response in KIT-Altered Melanoma: A Phase II Multicenter Trial of the French Skin Cancer Network
18. Combined Nivolumab and Ipilimumab in Octogenarian and Nonagenarian Melanoma Patients
19. First-line rituximab combined with short-term prednisone versus prednisone alone for the treatment of pemphigus (Ritux 3): a prospective, multicentre, parallel-group, open-label randomised trial
20. Risk of autoimmune diseases and human papilloma virus (HPV) vaccines: Six years of case-referent surveillance
21. High-Resolution Elastography for Thin-Layer Mechanical Characterization: Toward Skin Investigation
22. FASCE, the benefit of spironolactone for treating acne in women: study protocol for a randomized double-blind trial
23. One-step surgical removal of cutaneous melanoma with surgical margins based on preoperative ultrasound measurement of the thickness of the melanoma
24. A high neutrophil to lymphocyte ratio prior to BRAF inhibitor treatment is a predictor of poor progression-free survival in patients with metastatic melanoma
25. Efficacy of imiquimod in the management of lentigo maligna
26. Efficacy of Methotrexate Alone vs Methotrexate Plus Low-Dose Prednisone in Patients With Alopecia Areata Totalis or Universalis
27. A high neutrophil-to-lymphocyte ratio as a potential marker of mortality in patients with Merkel cell carcinoma: A retrospective study
28. Sustained Remission Without Corticosteroids Among Patients With Pemphigus Who Had Rituximab as First-Line Therapy: Follow-Up of the Ritux 3 Trial
29. Partial response of metastatic melanoma to BRAF-inhibitor-monotherapy in a pregnant patient with no fetal toxicity
30. Incidence and Clinical Impact of Anti-TNFα Treatment of Severe Immune Checkpoint Inhibitor-induced Colitis in Advanced Melanoma: The Mecolit Survey
31. Spironolactone is Superior in Efficacy Compared to Doxycycline in Moderate Adult Female Acne: Results from the Multi-Center, Controlled, Randomized, Double-Blind Prospective and Parallel FASCE Study
32. Clostridium difficile infection and immune checkpoint inhibitor–induced colitis in melanoma: 18 cases and a review of the literature
33. High-frequency ultrasound imaging for cutaneous neurofibroma in patients with neurofibromatosis type I
34. High-frequency ultrasonography helps to confirm the diagnosis of multiple miliary osteoma cutis
35. Impact of Distribution of a Tip Sheet to Increase Early Detection and Prevention Behavior among First-Degree Relatives of Melanoma Patients: A Randomized Cluster Trial
36. Dermatite herpétiforme
37. Étude comparative de la mortalité des patients atteints de pemphigus selon l’utilisation du rituximab ou de traitements conventionnels
38. Résultats finaux d’une cohorte de 705 patients atteints de mélanome avancé et ayant débuté un traitement par pembrolizumab au cours de son programme français d’ATU
39. Infection à Clostridium difficile et colite auto-immune sous immunothérapie dans le mélanome : étude rétrospective de 18 cas
40. Réponse clinique et radiologique de mélanomes BRAF p.Thr599dup mutés, sous inhibiteurs de la voie MAP kinase
41. Clostridium difficileinfection and immune checkpoint inhibitor–induced colitis in melanoma: 18 cases and a review of the literature
42. sQuiz your knowledge: A solitary asymptomatic nodule on the arm
43. The Clinical Spectrum and Therapeutic Management of Hypocomplementemic Urticarial Vasculitis: Data From a French Nationwide Study of Fifty-Seven Patients
44. Preoperative Measurement of Thickness of Cutaneous Melanoma Using High-Resolution 20 MHz Ultrasound Imaging: A Monocenter Prospective Study and Systematic Review of the Literature
45. Absence of Inferior Labial and Lingual Frenula in Ehlers-Danlos Syndrome: A Minor Diagnostic Criterion in French Patients
46. Diagnosis of Oral Lesions
47. Recurrent primary cutaneous mucinous carcinoma with neuroendocrine differentiation: case report and review of the literature
48. Locoregional Multiple Nodular Panniculitis Induced by Pseudomonas aeruginosa Without Septicemia: Three Cases and Focus on Predisposing Factors
49. The Risk of Systemic Lupus Erythematosus Associated With Vaccines: An International Case-Control Study
50. Improvement of Survival in Patients With Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type, in France
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.